Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marco Valenti

Showing results (111-120 of 122) with videos related to

Pageof 13
Sort By:
Frontiers in Oncology|July 19, 2021
FDG-PET/CT in the Radiotherapy Treatment Planning of Locally Advanced Anal Cancer: A Monoinstitutional ExperienceClelia Di Carlo, Maika di Benedetto, Lisa Vicenzi, et al.
BMC Cancer|June 16, 2022
Circulating tumour cell gene expression and chemosensitivity analyses: predictive accuracy for response to multidisciplinary treatment of patients with unresectable refractory recurrent rectal cancer or unresectable refractory colorectal cancer liver metastasesStefano Guadagni, Francesco Masedu, Giammaria Fiorentini, et al.
Clinical Rheumatology|October 27, 2016
Biologic therapies and infections in the daily practice of three Italian rheumatologic units: a prospective, observational studyPaola Cipriani, Onorina Berardicurti, Francesco Masedu, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|October 26, 2007
Transabdominal ultrasonography, computed tomography and electronic portal imaging for 3-dimensional conformal radiotherapy for prostate cancerBarbara Alicja Jereczek-Fossa, Federica Cattani, Cristina Garibaldi, et al.
Rheumatology (Oxford, England)|April 19, 2022
Cytokine profile, ferritin and multi-visceral involvement characterize macrophage activation syndrome during adult-onset Still's diseasePiero Ruscitti, Francesco Ursini, Onorina Berardicurti, et al.
Plos Medicine|September 13, 2019
Anti-interleukin-1 treatment in patients with rheumatoid arthritis and type 2 diabetes (TRACK): A multicentre, open-label, randomised controlled trialPiero Ruscitti, Francesco Masedu, Saverio Alvaro, et al.
Physica Medica : PM : an International Journal Devoted to the Applications of Physics to Medicine and Biology : Official Journal of the Italian Association of Biomedical Physics (AIFB)|December 20, 2022
EFOMP's protocol quality controls in PET/CT and PET/MRRoberta Matheoud, Ronald Boellaard, Lucy Pike, et al.
Tumori|September 9, 2023
Impact of inter-observer variability on first axillary level dosimetry in breast cancer radiotherapy: An AIRO multi-institutional studyMaria Cristina Leonardi, Matteo Pepa, Mattia Zaffaroni, et al.
The British Journal of Radiology|April 21, 2021
Geometric contour variation in clinical target volume of axillary lymph nodes in breast cancer radiotherapy: an AIRO multi-institutional studyMaria Cristina Leonardi, Matteo Pepa, Simone Giovanni Gugliandolo, et al.
RMD Open|November 21, 2023
Derivation and validation of four patient clusters in Still's disease, results from GIRRCS AOSD-study group and AIDA Network Still Disease RegistryPiero Ruscitti, Francesco Masedu, Antonio Vitale, et al.
Pageof 13

Showing results (111-120 of 122) with videos related to

Sort By:
Pageof 13
Frontiers in Oncology|July 19, 2021
FDG-PET/CT in the Radiotherapy Treatment Planning of Locally Advanced Anal Cancer: A Monoinstitutional ExperienceClelia Di Carlo, Maika di Benedetto, Lisa Vicenzi, et al.
BMC Cancer|June 16, 2022
Circulating tumour cell gene expression and chemosensitivity analyses: predictive accuracy for response to multidisciplinary treatment of patients with unresectable refractory recurrent rectal cancer or unresectable refractory colorectal cancer liver metastasesStefano Guadagni, Francesco Masedu, Giammaria Fiorentini, et al.
Clinical Rheumatology|October 27, 2016
Biologic therapies and infections in the daily practice of three Italian rheumatologic units: a prospective, observational studyPaola Cipriani, Onorina Berardicurti, Francesco Masedu, et al.
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|October 26, 2007
Transabdominal ultrasonography, computed tomography and electronic portal imaging for 3-dimensional conformal radiotherapy for prostate cancerBarbara Alicja Jereczek-Fossa, Federica Cattani, Cristina Garibaldi, et al.
Rheumatology (Oxford, England)|April 19, 2022
Cytokine profile, ferritin and multi-visceral involvement characterize macrophage activation syndrome during adult-onset Still's diseasePiero Ruscitti, Francesco Ursini, Onorina Berardicurti, et al.
Plos Medicine|September 13, 2019
Anti-interleukin-1 treatment in patients with rheumatoid arthritis and type 2 diabetes (TRACK): A multicentre, open-label, randomised controlled trialPiero Ruscitti, Francesco Masedu, Saverio Alvaro, et al.
Physica Medica : PM : an International Journal Devoted to the Applications of Physics to Medicine and Biology : Official Journal of the Italian Association of Biomedical Physics (AIFB)|December 20, 2022
EFOMP's protocol quality controls in PET/CT and PET/MRRoberta Matheoud, Ronald Boellaard, Lucy Pike, et al.
Tumori|September 9, 2023
Impact of inter-observer variability on first axillary level dosimetry in breast cancer radiotherapy: An AIRO multi-institutional studyMaria Cristina Leonardi, Matteo Pepa, Mattia Zaffaroni, et al.
The British Journal of Radiology|April 21, 2021
Geometric contour variation in clinical target volume of axillary lymph nodes in breast cancer radiotherapy: an AIRO multi-institutional studyMaria Cristina Leonardi, Matteo Pepa, Simone Giovanni Gugliandolo, et al.
RMD Open|November 21, 2023
Derivation and validation of four patient clusters in Still's disease, results from GIRRCS AOSD-study group and AIDA Network Still Disease RegistryPiero Ruscitti, Francesco Masedu, Antonio Vitale, et al.
Pageof 13